TY - JOUR AU - Williams, G. R. AU - Jiang, J. G. AU - Matchar, D. B. AU - Samsa, G. P. PY - 1999 DA - 1999// TI - Incidence and occurrence of total (first-ever and recurrent) stroke JO - Stroke VL - 30 UR - https://doi.org/10.1161/01.STR.30.12.2523 DO - 10.1161/01.STR.30.12.2523 ID - Williams1999 ER - TY - JOUR AU - Yusuf, S. AU - Reddy, S. AU - Ounpuu, S. PY - 2001 DA - 2001// TI - Global burden of cardiovascular diseases, I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization JO - Circulation VL - 104 UR - https://doi.org/10.1161/hc4601.099487 DO - 10.1161/hc4601.099487 ID - Yusuf2001 ER - TY - JOUR AU - Frick, M. H. AU - Syvanne, M. AU - Nieminen, M. S. PY - 1997 DA - 1997// TI - Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol JO - Circulation VL - 96 UR - https://doi.org/10.1161/01.CIR.96.7.2137 DO - 10.1161/01.CIR.96.7.2137 ID - Frick1997 ER - TY - JOUR AU - Syvanne, M. AU - Nieminen, M. S. AU - Frick, M. H. PY - 1998 DA - 1998// TI - Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with Gemfibrozil in men with low baseline levels of HDL cholesterol JO - Circulation VL - 98 UR - https://doi.org/10.1161/01.CIR.98.19.1993 DO - 10.1161/01.CIR.98.19.1993 ID - Syvanne1998 ER - TY - JOUR AU - Amarenco, P. AU - Labreuche, J. PY - 2009 DA - 2009// TI - Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention JO - Lancet Neurol VL - 8 UR - https://doi.org/10.1016/S1474-4422(09)70058-4 DO - 10.1016/S1474-4422(09)70058-4 ID - Amarenco2009 ER - TY - JOUR AU - Austin, M. A. AU - King, M. -. C. AU - Vranizan, K. M. AU - Krauss, R. M. PY - 1990 DA - 1990// TI - Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk JO - Circulation VL - 82 UR - https://doi.org/10.1161/01.CIR.82.2.495 DO - 10.1161/01.CIR.82.2.495 ID - Austin1990 ER - TY - JOUR AU - Frick, M. H. AU - Elo, O. AU - Haapa, K. PY - 1987 DA - 1987// TI - Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease JO - N Engl J Med VL - 317 UR - https://doi.org/10.1056/NEJM198711123172001 DO - 10.1056/NEJM198711123172001 ID - Frick1987 ER - TY - JOUR PY - 2000 DA - 2000// TI - Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. The bezafibrate infarction prevention (BIP) study JO - Circulation VL - 102 UR - https://doi.org/10.1161/01.CIR.102.1.21 DO - 10.1161/01.CIR.102.1.21 ID - ref8 ER - TY - JOUR AU - Brunzell, J. D. PY - 2007 DA - 2007// TI - Hypertriglyceridemia JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMcp070061 DO - 10.1056/NEJMcp070061 ID - Brunzell2007 ER - TY - JOUR AU - Rubins, H. B. AU - Robins, S. J. AU - Collins, D. PY - 1999 DA - 1999// TI - Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199908053410604 DO - 10.1056/NEJM199908053410604 ID - Rubins1999 ER - TY - CHAP AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. PY - 2009 DA - 2009// TI - Preferred Reporting Items for Systematic Reviews and Meta-Analysis: The PRISMA Statement BT - Plos Medicine ID - Moher2009 ER - TY - JOUR AU - Jadad, A. R. AU - Moore, R. A. AU - Carroll, D. PY - 1996 DA - 1996// TI - Assessing the quality of reports of randomized clinical trials: is blinding necessary? JO - Control Clin Trials VL - 17 UR - https://doi.org/10.1016/0197-2456(95)00134-4 DO - 10.1016/0197-2456(95)00134-4 ID - Jadad1996 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Ades, A. E. AU - Lu, G. AU - Higgins, J. P. PY - 2005 DA - 2005// TI - The interpretation of random-effects meta-analysis in decision models JO - Med Decis Making VL - 25 UR - https://doi.org/10.1177/0272989X05282643 DO - 10.1177/0272989X05282643 ID - Ades2005 ER - TY - CHAP AU - Deeks, J. J. AU - Higgins, J. P. T. AU - Altman, D. G. ED - Higgins, J. ED - Green, S. PY - 2008 DA - 2008// TI - Analyzing data and undertaking meta-analyses BT - Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 PB - The Cochrane Collaboration CY - Oxford, UK ID - Deeks2008 ER - TY - JOUR AU - Egger, M. AU - Davey Smith, G. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Acheson, J. AU - Hutchinson, E. C. PY - 1972 DA - 1972// TI - Controlled trial of clofibrate in cerebral ascular disease JO - Atherosclerosis VL - 15 UR - https://doi.org/10.1016/0021-9150(72)90067-6 DO - 10.1016/0021-9150(72)90067-6 ID - Acheson1972 ER - TY - JOUR PY - 1973 DA - 1973// TI - The treatment of cerebrovascular disease with clofibrate. Final report of the veterans administration cooperative study of atherosclerosis, Neurology Section JO - Stroke VL - 4 UR - https://doi.org/10.1161/01.STR.4.4.684 DO - 10.1161/01.STR.4.4.684 ID - ref18 ER - TY - JOUR PY - 1975 DA - 1975// TI - Clofibrate and niacin in coronary heart disease JO - JAMA VL - 231 UR - https://doi.org/10.1001/jama.1975.03240160024021 DO - 10.1001/jama.1975.03240160024021 ID - ref19 ER - TY - JOUR PY - 1978 DA - 1978// TI - A co-operative trial in the primary prevention of ischemic heart disease using clofibrate, report from the committee of principal investigators JO - Br Heart J VL - 40 UR - https://doi.org/10.1136/hrt.40.10.1069 DO - 10.1136/hrt.40.10.1069 ID - ref20 ER - TY - JOUR AU - Meade, T. W. PY - 2001 DA - 2001// TI - Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER) trial of bezafibrate in men with lower extremity arterial disease JO - Curr Control Trials Cardiovasc Med VL - 2 UR - https://doi.org/10.1186/CVM-2-4-195 DO - 10.1186/CVM-2-4-195 ID - Meade2001 ER - TY - JOUR AU - Meade, T. AU - Zuhrie, R. AU - Cook, C. PY - 2002 DA - 2002// TI - Bezafibrate in men with lower extremity arterial disease: randomised controlled trial JO - BMJ VL - 325 UR - https://doi.org/10.1136/bmj.325.7373.1139 DO - 10.1136/bmj.325.7373.1139 ID - Meade2002 ER - TY - JOUR AU - Whitney, E. J. AU - Krasuski, R. A. AU - Personius, B. E. PY - 2005 DA - 2005// TI - A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events JO - Ann Intern Med VL - 142 UR - https://doi.org/10.7326/0003-4819-142-2-200501180-00008 DO - 10.7326/0003-4819-142-2-200501180-00008 ID - Whitney2005 ER - TY - JOUR PY - 2005 DA - 2005// TI - Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67667-2 DO - 10.1016/S0140-6736(05)67667-2 ID - ref24 ER - TY - JOUR PY - 2010 DA - 2010// TI - Effects of combination lipid therapy in type 2 diabetes mellitus JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa1001282 DO - 10.1056/NEJMoa1001282 ID - ref25 ER - TY - JOUR AU - Duvall, S. AU - Tweedie, R. PY - 2000 DA - 2000// TI - A nonparametric “trim and fill” method for assessing publication bias in meta-analysis JO - J Am Stat Assoc VL - 95 ID - Duvall2000 ER - TY - JOUR PY - 1994 DA - 1994// TI - Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the scandinavian simvastatin survival study (4S) JO - Lancet VL - 344 ID - ref27 ER - TY - JOUR PY - 1998 DA - 1998// TI - Prevention of cardiovascular events and death with pravaststin in patients with coronary heart disease and a broad range of initial cholesterol levels JO - New Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199811053391902 DO - 10.1056/NEJM199811053391902 ID - ref28 ER - TY - JOUR AU - Sacks, F. M. AU - Pfeffer, M. A. AU - Moye, L. A. PY - 1996 DA - 1996// TI - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels JO - New Engl J Med VL - 335 UR - https://doi.org/10.1056/NEJM199610033351401 DO - 10.1056/NEJM199610033351401 ID - Sacks1996 ER - TY - JOUR AU - White, H. D. AU - Simes, R. J. AU - Anderson, N. E. PY - 2000 DA - 2000// TI - Pravastatin therapy and the risk of stroke JO - New Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200008033430502 DO - 10.1056/NEJM200008033430502 ID - White2000 ER - TY - JOUR AU - Tanne, D. AU - Yaari, S. AU - Goldbourt, U. PY - 1997 DA - 1997// TI - High-density lipoprotein cholesterol and risk of ischaemic stroke mortality JO - Stroke VL - 28 UR - https://doi.org/10.1161/01.STR.28.1.83 DO - 10.1161/01.STR.28.1.83 ID - Tanne1997 ER - TY - JOUR AU - Lindenstrom, E. AU - Boysen, G. AU - Nyboe, J. PY - 1994 DA - 1994// TI - Influence of total cholesterol, high density lipoprotein cholesterol and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study JO - Br Med J VL - 309 UR - https://doi.org/10.1136/bmj.309.6946.11 DO - 10.1136/bmj.309.6946.11 ID - Lindenstrom1994 ER - TY - JOUR PY - 1995 DA - 1995// TI - Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 45,0000 people in 45 prospective cohorts JO - Lancet VL - 346 UR - https://doi.org/10.1016/S0140-6736(95)92836-7 DO - 10.1016/S0140-6736(95)92836-7 ID - ref33 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/13/1/prepub UR - http://www.biomedcentral.com/1471-2377/13/1/prepub ID - ref34 ER -